天美传媒

Abstract

Next-Generation Sequencing (NGS) has revolutionized oncology drug development by providing unprecedented insights into the genetic and molecular underpinnings of cancer. NGS technologies enable comprehensive genomic profiling of tumors, facilitating the identification of actionable mutations, structural variations, and epigenetic changes. This high-resolution genetic landscape accelerates the discovery of novel therapeutic targets and biomarkers, allowing for more precise and personalized treatment strategies. By integrating NGS data with clinical outcomes, researchers can develop more effective and targeted therapies, reduce adverse effects, and improve patient prognosis. The application of NGS in oncology also supports the advancement of precision medicine, enabling the development of innovative drug formulations and optimizing clinical trial designs. Overall, NGS stands as a transformative tool in oncology, driving advancements in drug development and paving the way for more effective cancer treatments.